首页 › 基金 › Western Financial Corp/CA › ARWR
Western Financial Corp/CA 对 ARWR 的持仓历史
ARROWHEAD PHARMACEUTICALS IN · 医疗保健
Western Financial Corp/CA 在 Q3 2026 的 13F 申报中披露持有 ARWR(ARROWHEAD PHARMACEUTICALS IN)820,239 股,市值约 US$53.7M,约占其申报组合的 17.87%,在其申报持仓中市值排名第 1 位。 Western Financial Corp/CA 最近 13 个申报季度中有 13 个季度披露了 ARWR 持仓,最早可追溯至 Q3 2023。
最后更新: 2026-10-15 · 来源: SEC EDGAR Form 13F-HR
Western Financial Corp/CA 对 ARWR 的持仓演变
Western Financial Corp/CA 于 Q3 2023 首次披露 ARWR 持仓:820,239 股(约 US$22.0M)。 该持仓在 Q2 2026 达到峰值 820,239 股,市值约 US$66.9M。 在 13 次申报中,Western Financial Corp/CA 的持股数量始终未变。 最近一期申报(Q3 2026)显示持股 820,239 股、市值约 US$53.7M。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2023 | 820.24K | $22.04M | 新进 |
| Q4 2023 | 820.24K | $25.10M | 持有 |
| Q1 2024 | 820.24K | $23.46M | 持有 |
| Q2 2024 | 820.24K | $21.32M | 持有 |
| Q3 2024 | 820.24K | $15.89M | 持有 |
| Q4 2024 | 820.24K | $15.42M | 持有 |
| Q1 2025 | 820.24K | $10.45M | 持有 |
| Q2 2025 | 820.24K | $12.96M | 持有 |
| Q3 2025 | 820.24K | $28.29M | 持有 |
| Q4 2025 | 820.24K | $54.46M | 持有 |
| Q1 2026 | 820.24K | $51.43M | 持有 |
| Q2 2026 | 820.24K | $66.86M | 持有 |
| Q3 2026 | 820.24K | $53.68M | 持有 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 ARWR 与 13F 数据
ARWR(ARROWHEAD PHARMACEUTICALS IN)属于医疗保健行业。我们追踪的基金中还有 52 只申报持有 ARWR,申报仓位最大的包括:Avoro Capital Advisors LLC (US$925.6M), FRED ALGER MANAGEMENT, LLC (US$269.1M), BAKER BROS. ADVISORS LP (US$162.4M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 ARWR 的基金
- Avoro Capital Advisors LLC 11.36M 股 · $925.59M · Q2 2026
- FRED ALGER MANAGEMENT, LLC 3.30M 股 · $269.14M · Q2 2026
- BAKER BROS. ADVISORS LP 1.99M 股 · $162.43M · Q2 2026
- Siren, L.L.C. 1.72M 股 · $139.83M · Q2 2026
- Vestal Point Capital, LP 1.57M 股 · $128.38M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 1.39M 股 · $113.22M · Q2 2026
- DRIEHAUS CAPITAL MANAGEMENT LLC 1.35M 股 · $110.08M · Q2 2026
- Hood River Capital Management LLC 1.12M 股 · $91.35M · Q2 2026
- SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 830.25K 股 · $67.67M · Q2 2026
- READYSTATE ASSET MANAGEMENT LP 25.00M 股 · $29.94M · Q2 2026
- MACKAY SHIELDS LLC 27.19M 股 · $27.84M · Q3 2026
更多关于 Western Financial Corp/CA
常见问题
How long has Western Financial Corp/CA held ARWR?
Western Financial Corp/CA has disclosed ARWR holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Western Financial Corp/CA's current position in ARWR?
As of Q3 2026, Western Financial Corp/CA holds 820.24K shares of ARWR (ARROWHEAD PHARMACEUTICALS IN), valued at $53.68M, representing 17.87% of its reported portfolio and ranking #1.
Has Western Financial Corp/CA been buying or selling ARWR?
In the latest 13F filing (Q3 2026), Western Financial Corp/CA held unchanged its position in ARWR. The position peaked in Q2 2026 at 820.24K shares.
Which other funds hold ARWR?
Other major institutional holders of ARWR include Avoro Capital Advisors LLC, FRED ALGER MANAGEMENT, LLC, BAKER BROS. ADVISORS LP, among 52 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.